Works matching IS 15228517 AND DT 2023 AND VI 25 AND IP 3
Results: 11
Corrigendum to: Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C.
- Published in:
- 2023
- Publication type:
- Correction Notice
Society News.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 616, doi. 10.1093/neuonc/noad023
- Publication type:
- Article
Advances in palliative care in neuro-oncology come in many forms.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 457, doi. 10.1093/neuonc/noac287
- By:
- Publication type:
- Article
Exploiting radiation immunostimulatory effects to improve glioblastoma outcome.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 433, doi. 10.1093/neuonc/noac239
- By:
- Publication type:
- Article
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 520, doi. 10.1093/neuonc/noac224
- By:
- Publication type:
- Article
Palliative care and end-of-life care in adults with malignant brain tumors.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 447, doi. 10.1093/neuonc/noac216
- By:
- Publication type:
- Article
In vivo functional characterization of EGFR variants identifies novel drivers of glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 471, doi. 10.1093/neuonc/noac215
- By:
- Publication type:
- Article
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 508, doi. 10.1093/neuonc/noac206
- By:
- Publication type:
- Article
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 495, doi. 10.1093/neuonc/noac194
- By:
- Publication type:
- Article
Cross-platform analysis reveals cellular and molecular landscape of glioblastoma invasion.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 482, doi. 10.1093/neuonc/noac186
- By:
- Publication type:
- Article
ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 459, doi. 10.1093/neuonc/noac179
- By:
- Publication type:
- Article